Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis

ConditionKnee Osteoarthritis

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age40+

SponsorPharmaResearch Co.,Ltd

About this trial

This clinical trial aims to evaluate and compare the efficacy and safety of Conjuran® and Hyruan in patients with knee osteoarthritis following first and second cycle (repeat) administration.

Eligibility criteria

Qualifiers

Age ≥40 years

Knee osteoarthritis diagnosed according to ACR criteria

KL grade I-III

Weight-bearing pain VAS ≥40 mm

Disqualifiers

Inflammatory or secondary arthritis

Recent treatment in the target knee

Significant uncontrolled medical conditions

Hypersensitivity to study device components

Trial design

Treatments tested in this trial

Conjuran
Hyruan

Treatment groups

180 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

PharmaResearch Co.,Ltd

Lead sponsor

Source ClinicalTrials.gov